The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

The Oncology Institute, Inc.NASDAQ: TOI

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin grows, but more slowly than its trailing trend

Q1 FY2026 selling, general & admin of $28.21M rose 11.2% year over year, behind the +62.2% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.6% from the prior quarter.

Context

  • Selling, general & admin amounted to 21.0% of revenue in FY2025, up 21.0 pp from a year earlier.
  • Selling, general & admin increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 3 analysts of $27.5M (-74.0%) for the fiscal year ending Dec 2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$28.21M+0.6% QoQ
Last fiscal yearDec 2025
$105.57M— YoY
LTMMar 2026
$81.5M+62.2% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.2%——
1 year—-74.0%—
3-year CAGR—-24.3%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
105.57M USD
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +62.2% is the highest of 10, against a peer median of +3.1%.
  • Selling, general & admin amounts to 14.9% of revenue for TOI, versus a peer median of 71.6%.
TOI Competitors
Selling, General & Admin for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 903.29M PEN+10.1%+15.2%20.0%
AGLAgilon Health, Inc.LTM Mar 2026$226.81M USD-12.2%+4.7%3.9%
EOLSEvolus, Inc.LTM Mar 2026$216.13M USD+3.1%+15.9%71.6%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$200.66M USD+0.0%+14.0%96.8%
KIDSOrthoPediatrics Corp.LTM Mar 2026$195.2M USD+11.5%+22.8%80.2%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$147.11M USD-9.3%-14.8%14.7%
AUTLAutolus Therapeutics plcLTM Mar 2026$142.24M USD+17.3%+60.5%153.6%
CBLLCeriBell, Inc.LTM Mar 2026$127.27M USD+37.1%+32.7%133.9%
TOIThe Oncology Institute, Inc.LTM Mar 2026$81.5M USD+62.2%—14.9%
SNDASonida Senior Living, Inc.LTM Mar 2026$41.84M USD+2.6%+9.6%10.2%
Peer median (excluding TOI) —+3.1%+15.2%71.6%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.